The molecular characteristics of thiamin (T) transport were studied in the small intestinal and renal brush border membrane vesicles of rats, using [ 3 H]T at high specific activity. The effects of various chemical modifiers (amino acid blockers) on T uptake were examined and their specificity assessed. Treatment with the carboxylic specific blockers 1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate, (1-ethyl-3-[3-(dimethylamino)propyl]-carbodiimide hydrochloride and N-ethyl-5-phenylisoaxolium-3P-sulfonate (Woodward's Reagent K) and with the sulfhydryl specific blocker p-chloromercuribenzene sulfonate inhibited T transport in both types of vesicles. Phenylglyoxal, but not ninhydrin, both reagents for arginine residues, and diethylpyrocarbonate, a reagent for histidine residues, specifically decreased T transport only in renal and small intestinal vesicles respectively. Similarly 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole reacted, but not N-acetylimidazole, both of which are reagents for tyrosine residues. However, 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole inhibition was aspecific. Acetylsalicylic acid, a reagent for lysine and serine residues, decreased T transport, but the lysine effect was aspecific. Acetylsalicylic acid serine blockage also eliminated T/H exchange in small intestinal vesicles. Taken together, these results suggest that for T transport carboxylic and sulfhydryl groups and serine residues are essential in both renal and small intestinal brush border membrane vesicles. In addition, arginine and histidine residues are also essential respectively for renal and small intestinal transporters. Serine was essential for the T/H antiport mechanism. ß
Introduction
Thiamin (T) entry into rat enterocytes, as evaluated in brush border membrane vesicles (BBMVs), is a saturable, carrier mediated process at low (physiological) concentrations [1, 2] , which is Na and K independent and involves a T/H antiport mechanism [3] , inhibited by T analogs and derivatives.
T plasma level is, in part, regulated, like that of other organic cations, by the kidney. At high plasma levels organic cations are actively secreted [4] , whereas at low plasma levels they can be actively reabsorbed [5, 6] . T in rat plasma is not protein bound [7^9] and, under normal conditions, is reabsorbed, rather than secreted by the proximal tubule [10] . Recently a T/H exchange mechanism has been identi-¢ed in rat renal BBMVs [11] , with features resembling those of rat enterocytes. The molecular characteristics of T microvillous intestinal and renal transporters have been little investigated. Komai and Shindo [12] , using everted ring segments of the rat small intestine, put forward a preliminary hypothesis about the structure of the T transport system. On the basis of their results, both the amino group and the quaternary nitrogen atom of the vitamin have been recognized as being required for T transport, with 2P-methyl and 5-hydroxyethyl groups signi¢cantly in£uencing T binding to the carrier. Iwashima et al. [13] found a T binding protein located in the cytoplasmic membrane of yeast cells. Chemical modi¢cation of this protein suggests that an ionic interaction between a carboxyl residue and a quaternary nitrogen atom of the thiazole moiety of the T molecule could be involved in T binding to the protein. Recently this transporter has been cloned [14] .
In the present study, we chemically modi¢ed some amino acid residues exposed to the right-side-out BBMVs of the rat small intestine and kidney, and examined the consequences on T transport. Preliminarily, the e¡ect of various chemical modi¢ers on T uptake by intestinal and renal BBMVs was evaluated. The modi¢ers used were: CMC (1-cyclohexyl-3-(2-morpholinoethyl) carbodiimide metho-p-toluene sulfonate), EDC (1-ethyl-3-[3-(dimethylamino)-propyl]-carbodiimide hydrochloride) and WRK (or Woodward's Reagent K, N-ethyl-5-phenylisoaxolium-3P-sulfonate) for carboxylic groups; PCMBS (p-chloromercuribenzene sulfonate) and DTNB (5,5P-dithiobis (2-nitrobenzoic acid)) for sulfhydryl groups; PGO (phenylglyoxal) and NIN (ninhydrin) for arginine residues; DEPC (diethyl pyrocarbonate) for histidine residues; NAI (N-acetylimidazole) and NBD-Cl (7-chloro-4-nitrobenzo-2-oxa-1,3-diazole) for tyrosine residues; PLP (pyridoxal 5P-phosphate) and SAL (acetylsalicylic acid) for lysine and serine residues. Successively the speci¢city of action of each chemical modi¢er was also examined.
Materials and methods

Animals
Adult Wistar albino rats (250^300 g body weight)
of either sex, reared on a complete standard diet containing 12 Wg/g T [15] , were used. Animals were killed by decapitation after 12 h fasting with water ad libitum.
Preparation of BBMVs
Intestinal BBMVs were prepared from the duodenal and jejunal mucosa of six adult rats using a Mg 2 /EGTA precipitation method as described by Rindi and Laforenza [16] . This method gives a lower puri¢cation, but it does not modify proton conductance [17] . All procedures were carried out at 0^4³C. The purity of the microvillous membrane was estimated by assessing the enrichment in alkaline phosphatase and K -phosphatase activities of BBMVs, determined according to Murer et al. [18] , as compared to the initial mucosal homogenate. The enrichment of BBMVs was 15.1 þ 1.3 for alkaline phosphatase, and 1.6 þ 1.2 for K -phosphatase (mean þ S.E.M. of ¢ve di¡erent preparations).
Renal BBMVs were prepared from the kidney cortex of ¢ve or six rats using the Mg 2 /EGTA precipitation method of Biber et al. [19] . The enrichments were 15.5 þ 0.8 for alkaline phosphatase, and 1.6 þ 0.3 for K -phosphatase (mean þ S.E.M. of ¢ve di¡erent preparations).
Protein content was measured according to Lowry et al. [20] , using bovine serum albumin as a standard.
Transport e¤ciency of BBMVs
The transport e¤ciency of the small intestinal and renal vesicular preparations was evaluated by determining the time course pro¢le of D-glucose uptake after incubation with 80 WM D-[U-
14 C]glucose (speci¢c activity, 0.31 GBq/mmol) as described by Casirola et al. [2] . The time course pro¢le of D-glucose uptake in the presence of an initial 100 mM NaCl gradient (out s in) showed an overshoot at 6^45 s, which disappeared in the presence of a 100 mM KCl gradient. This time course was similar to that reported in the literature [21] .
Thiamin uptake
BBMVs were incubated at 25³C in a solution containing (mM): 250 D-mannitol, 20 Tris^HEPES (pH 7.5) and 1 WM [ 3 H]T (speci¢c activity, 27.75 GBq/ mmol). 10 Wl of vesicle suspension was rapidly mixed with 90 Wl of transport medium, and the incubation was terminated by the addition of 3 ml of cold (04 ³C) stopping solution (150 mM NaCl, 1 mM TrisĤ EPES, pH 7.5). The amount of T radioactivity taken up by the vesicles was radiometrically measured after their separation by a rapid ¢ltration procedure using cellulose nitrate micro¢lters (Micro¢ltration System, Dublin, CA, USA; pore diameter, 0.65 Wm) previously saturated with unlabelled T [2] . Blanks were prepared in each experiment to evaluate the radioactivity of [ 3 H]T non-speci¢cally adsorbed in the ¢lter. The values of blanks were subtracted from the total radioactivity retained in the ¢lter. Radiometric measurements were made using a Packard Tri-Carb 2000 CA liquid scintillation counter (Packard Instrument, Downers Grove, IL, USA). Unless stated otherwise, all uptake values were means þ S.E.M. of at least triplicate determinations for each of the ¢ve di¡erent vesicle preparations.
Short-time incubations
For 15 s incubation time a STRUMA short-time incubation apparatus (Innovativ-Labor, Adliswill, Switzerland) was used.
Chemical modi¢cation of BBMVs
Control vesicles were always processed in the same conditions (time, pH, temperature and solutions) of BBMVs treated with speci¢c blockers. Potential changes in osmolarity due to the addition of chemical modi¢ers, dithiothreitol (DTT), hydroxylamine and free amino acids were prevented by adding an isoosmotic amount of D-mannitol in control vesicle incubating solutions. In protection experiments, free amino acids were added in the incubation media in a molar ratio 40% higher than that of blockers.
Moreover, to distinguish between negative results and false negatives, when a chemical modi¢er did not a¡ect T transport, higher concentrations of reagents were utilized.
Carboxylic groups
Carboxylic groups were blocked with 20 mM CMC or with 20 mM EDC following George and Borders [22] , or even with 5 mM WRK following Dinur et al. [23] .
Sulfhydryl groups
Sulfhydryl groups were blocked with 1.5 mM DTNB [24] or with 1 mM PCMBS [25, 26] . In some experiments BBMVs pretreated with 1 mM PCMBS were further incubated at 25³C with 10 mM DTT, 20 mM HEPES^Tris (pH 7.0) and isoosmotic D-mannitol for 10 min [25] .
Arginine residues
Arginine residues were blocked with PGO or NIN. BBMVs were incubated with 50 mM PGO at 25³C
[27^29] or with 1 mM NIN at 37³C in the dark [30, 31] (see legend to Fig. 3 ). In some experiments, BBMVs were incubated at 25³C with 50 mM PGO plus 70 mM L-histidine.
Histidine residues
Histidine residues were blocked with DEPC [32] . In some experiments, to test the speci¢city of the reaction, BBMVs pretreated with 5 mM DEPC were further incubated at 25³C with 200 mM hydroxylamine and 60 mM Tris^HEPES (pH 6.0) for 30 min, or with 10 mM DTT, 20 mM HEPES^Tris (pH 6.5) and isoosmotic D-mannitol for 10 min [26, 33] . In addition, speci¢city was also evaluated by treating BBMVs with 5 mM DEPC, 7 mM Larginine, 20 mM K 2 HPO 4 /KH 2 PO 4 (pH 6.5) and isoosmotic D-mannitol at 25³C for 30 min.
Tyrosine residues
Tyrosine residues were blocked with 1 mM NBDCl following Lin et al. [34] or with 5 mM NAI following Hori et al. [26] .
Lysine residues
Lysine residues were blocked with 2 mM PLP following Haghighi et al. [35] .
Serine residues
The e¡ect of the serine residue modi¢er SAL (10 mM) was tested following Han et al. [36] . For speci¢city, in some experiments BBMVs were treated at 25³C with 10 mM SAL, 14 mM L-serine, 70 mM Tris^HCl (pH 7.5) and isoosmotic D-mannitol for 20 min.
Finally, the e¡ect of serine residue blockage on T/H exchange was investigated using intestinal BBMVs treated with SAL and preequilibrated (see [3] 
Washing procedures
The reaction of BBMVs with the chemical modi¢ers was stopped by adding 10 volumes of an ice cold solution containing (mM): 250 D-mannitol, 20 Tris^HEPES, pH 7.5. The BBMVs were then centrifuged at 27 000Ug for 20 min, repeating the step twice with 5 volumes of the same medium [26, 28, 37, 38] . After washing, the vesicles were immediately utilized for uptake experiments.
Statistics
The signi¢cance of the di¡erences in the means under di¡erent experimental conditions was evaluated using the following statistical methods: analysis of variance (ANOVA) followed by NewmanK euls's Q-test; Student's t-test for paired data. All statistical methods were carried out using a computerized program [39] . 
Results
In preliminary experiments, the possible alteration of passive permeability due to vesicle treatment was tested by measuring T uptake at 0³C. Results showed that passive permeability of T was una¡ected by all chemical modi¢ers utilized (A. Verri, unpublished data).
In treated and control vesicles from both kidney and small intestine T uptake reached equilibrium already after 15 s incubation. This can be, at least in part, ascribed to the presence of a binding component that, in the absence of a pH gradient, is about 50% of total T uptake [3, 11] .
Carboxylic groups
All the carboxylic group blockers signi¢cantly inhibited total T uptake in both small intestinal and renal BBMVs (Fig. 1) . In renal BBMVs CMC and EDC showed inhibition potencies higher than WRK.
Sulfhydryl groups
PCMBS produced on T transport an average inhibition of 50% and 44% in renal and intestinal BBMVs respectively, while DTNB was ine¡ective (Fig. 2) . Moreover, at 15 s incubation PCMBS inhibition (65% þ 4 and 44% þ 14 for renal and small intestinal vesicles respectively) of T uptake was reversed by further treatment of both types of vesicles with 10 mM DTT, which can reverse the inhibition of sulfhydryl groups. Percent inhibition of T uptake, 2.5 þ 3 and 0.6 þ 7 in renal and small intestinal vesicles respectively, became negligible.
Arginine residues
In renal and small intestinal BBMVs T uptake was inhibited by PGO to about 55% and 30% respectively (Fig. 3) ; in contrast, NIN failed to inhibit. Since NIN was ine¡ective and PGO could also interact with histidine residues [40] , in some experiments, both renal and small intestinal vesicles were treated with PGO in the presence or absence of 70 mM of free L-histidine. The excess of L-histidine protected intestinal, but not renal vesicles (Fig. 4) . Therefore, the small intestinal BBMV inhibition was probably caused by PGO reacting with histidine rather than with arginine residues.
Histidine residues
Treatment of both renal and intestinal BBMVs with DEPC signi¢cantly lowered T uptake by about 30% (Fig. 3) . The inhibitory e¡ect of DEPC at 15 s incubation (amounting to 53% þ 5 and 38% þ 6 for renal and small intestinal vesicles respectively) was not reversed by treatment with either 10 mM DTT (i) or 200 mM hydroxylamine (ii), which are capable of reversing the inhibition of sulfhydryl groups and tyrosine residues respectively [26, 33] . Using these reagents, percent inhibition was (i) 67% þ 5 and 31% þ 9, and (ii) 43% þ 4 and 53% þ 10 vs. respective controls (vesicles incubated with DTT or hydroxylamine without DEPC) for renal and small intestinal vesicles respectively. Thus, under our experimental conditions, DEPC did not react with sulfhydryl groups and tyrosine residues, but only with histidine residues.
To exclude any cross reaction of DEPC with Larginine, intestinal and renal BBMV were treated with DEPC in the presence or absence of 7 mM of free L-arginine : L-arginine protected only renal vesicles (Fig. 4) .
Tyrosine residues
T uptake by both renal and intestinal BBMVs was signi¢cantly inhibited by NBD-Cl to about 60% up to 1 min incubation; the intestinal uptake was also reduced (by 25% decrease) at 5 min incubation (Fig.  5) . In contrast, the preincubation of the vesicles with the more speci¢c tyrosine blocker NAI did not inhibit T uptake [41, 42] .
Lysine and serine residues
SAL is a reagent for either lysine [43] or serine residues [44] . SAL treatment signi¢cantly reduced renal and intestinal vesicular T uptake by about 304 0% (Fig. 5) . In order to distinguish between L-lysine and L-serine involvement, BBMVs were treated with PLP, a lysine speci¢c blocker, in separate experiments [35] . T vesicular transport was not a¡ected by this treatment, showing that SAL speci¢cally interacted with serine residues.
In other experiments, renal and intestinal BBMVs were treated with SAL in the presence or in the absence of 14 mM free L-serine. L-Serine protected the vesicles from SAL action and T uptake did not di¡er signi¢cantly from that of vesicles treated with L-serine in the absence of SAL (controls). Percent inhibition accounted to only 2.8 þ 1 and 13 þ 4 in renal and small intestinal vesicles respectively.
Serine residues and T/H exchange
The time course of T uptake by intestinal BBMVs in the presence of an outwardly directed H gradient (pH in 5:pH out 7.5) is shown in Fig. 6 . As can be seen, the overshoot uptake of T was virtually eliminated by vesicle pretreatment with 10 mM SAL, indicating that serine plays an essential role in the T/H exchange mechanism.
Discussion
Several reports indicate that a carrier-mediated T transport system is present in the apical membrane of the small intestine and kidney of mammals [1^3,11,12,45^48], but little is known about the molecular structure of the T transporter, and what is known is con¢ned to the small intestine [12] . The present study is the ¢rst approach towards identifying the amino acids involved in the intestinal and renal transmembrane T transporter by inducing modi¢cations in the proteins of renal and small intestinal rat BBMVs. The functional e¤ciency of our BBMV preparations, evaluated as the time course of D-glucose uptake (A. Verri, unpublished data), and their purity, evaluated as the enrichment of alkaline phosphatase and K -activated phosphatase activities, were similar to those reported in the literature and are considered sound for transport studies.
Chemically, T is an organic cation which exists as a monovalent cation at physiological pHs (range, 5^7.4) due to the presence of a quaternary nitrogen at the 3 position of the thiazole moiety. At pHs high- Fig. 4 . E¡ect of L-histidine and L-arginine on T uptake by rat intestinal and renal BBMVs treated with the L-arginine and L-histidine blockers PGO and DEPC respectively. Vesicles, treated with the blockers in the presence or absence of a large amount of the free amino acid target, were incubated as described in Fig. 1 for 15 s. Each bar represents mean þ S.E.M. of at least triplicate determinations for each of four di¡erent preparations. *P 6 0.05 vs. intestinal vesicles treated with PGO+L-histidine; **P 6 0.05 vs. renal vesicles treated with DEPC+L-arginine (ANOVA followed by Newman^Keuls's Q-test before transformation of the data as percent activity). er than 9.0, T is undissociated with the thiazole ring open, whereas, at pHs lower than 4.0, T exists as a divalent cation with nitrogen at the 1P position of the pyrimidine moiety protonated [12] . These data suggest the involvement of the carboxylic groups of T transporters in T binding [12, 13] .
Our results showed that carboxylic blockers inhibited either small intestinal or renal T uptake by about 50% (Fig. 1) . Since the carbodiimides CMC and EDC as well as the WRK are hydrophilic compounds [31] , which cannot cross biological membranes, it can be assumed that T can bind its transporter at the external cellular side. Moreover, as previously suggested [12, 13] , the quaternary nitrogen of the T thiazole moiety is probably responsible for the binding of T to the carboxylic groups of T transporters, it being the only quaternary nitrogen present at physiological pH.
By using DTNB and PCMBS, the presence of sulfhydryl groups in the molecular structure of the T transporter could be assessed. Only PCMBS inhibited the time course of T uptake in both types of vesicles (Fig. 2) . The inhibition was speci¢c, since DTT was able to remove the linkage with sulfhydryl groups, suggesting that the sulfhydryl blocker PCMBS probably inhibited the functional sulfhydryl groups of the T transporter.
DTNB, another sulfhydryl groups blocker, was unable to inhibit T uptake since it is an aromatic disul¢de with a greater steric impediment, preferring to react with denatured proteins [49] , which is not our case. An important role of sulfhydryl groups was observed for organic cation transporters [25, 50] and for H /ATPase [51] . Interestingly, our results would be in keeping with the hypothesis that T could cross the biological membranes as a thiazolium ring opened thiol species, interacting with membrane sulfhydryl groups during translocation [52^55].
The role played by arginine and histidine residues in the structure of T transporters was also investigated by using either PGO or DEPC. Both blockers inhibited renal and intestinal T uptake (Fig. 3) . Speci¢city experiments, while excluding any cross reaction by DEPC with sulfhydryl groups and tyrosine residues, suggested that PGO in the small intestinal BBMVs blocked histidine rather than arginine residues. In fact, vesicles preincubated with PGO in the presence of an L-histidine excess normally took up T (Fig. 4) . Vice versa, the presence of an L-arginine excess during DEPC treatment could protect renal but not small intestinal BBMVs (Fig. 4) . Taken together, these results suggest that the T transporter has essential arginine or histidine residues in the kidney and in the small intestine BBMVs respectively. Some H driven transport systems (symports and antiports), similar to the renal and small intestinal T/H antiport, possess essential histidine or arginine residues for their functioning [32, 56] . Probably, arginine and/or histidine are located at the H binding sites rather than at the organic and inorganic compound binding sites [26,56^59] . As previously suggested [12, 13] , the nitrogen at the 1P position of the pyrimidine moiety of T can react with a positive charge present in the amino acid sequence of the transporter. At physiological pH, both histidine and arginine residues meet this requirement [60] .
Blockers NBD-Cl and NAI allowed us to investigate the role of tyrosine residues in the T transport system. T uptake was inhibited by NBD-Cl, but not by NAI (Fig. 5) , an apparent discrepancy that could be explained by considering the speci¢city and the sensitivity of the two tyrosine blockers. NBD-Cl potentially can react with tyrosine, lysine and cysteine residues [42] . In our experiments, NBD-Cl interaction with L-lysine residues could be excluded, since at pH 7.4, the reaction of NBD-Cl with the amino group is almost negligible, taking place at pHs higher than 8 [61] . In addition, BBMV treatment with PLP, a speci¢c lysine blocker, did not modify T transport. Thus, the sites chemically modi¢ed by NBD-Cl could only be tyrosine and cysteine residues. Since NAI did not inhibit T uptake, the conclusion can be reached that NBD-Cl reacted with cysteine residues. This hypothesis was con¢rmed following the use of the sulfhydryl speci¢c reagent PCMBS, which signi¢cantly inhibited T uptake in both renal and small intestinal vesicles (Fig. 2) . However, it has previously been shown that NAI is the most selective tyrosine reagent, even though its inhibitory potency appears to be lower than that of NBD-Cl [41, 42] .
SAL, a blocker of serine residues, reduced T uptake in both renal and small intestinal BBMVs (Fig.  5) . The presence of a large amount of free L-serine during SAL treatment protected the vesicles, indicating strong competition for SAL between exogenous free L-serine and the transporter sites modi¢ed by SAL. However, SAL inhibition could not be ascribed to the blockage of L-lysine residues, the other amino acid target for SAL [36, 43, 44, 62] , since PLP, a speci¢c lysine blocker, was ine¡ective. It should be emphasized that the blockage of serine residues also impeded T/H exchange in intestinal (and in renal, A. Verri, unpublished data) BBMVs as was shown by the disappearance of the typical overshoot [3] , observed in untreated vesicles in the presence of an outwardly directed pH gradient (Fig. 6 ).
In conclusion, carboxyl groups, sulfhydryl groups and serine residues should be essential for T transport in both renal and small intestinal BBMVs. In addition, the renal transporter has essential arginine and the small intestinal histidine residues. The di¡er-ences in the sensitivity toward the chemical modi¢ers could also indicate that the renal transporter of T is di¡erent from the transporter present in small intestine. Thus, the existence of di¡erent transporters could account for the di¡erences in the transport capacity and speci¢city previously observed in kidney and small intestine [3, 11] .
It is interesting to compare our results on rats with those by Katsura et al. [50] , who applied our experimental approach to the same animals but with tetraethylammonium (TEA) instead of T as an organic cation. Here, the renal BBMV transporter of TEA was found to possess the essential carboxyl and sulfhydryl groups and histidine and arginine residues. Thus the renal T transporter would appear to be di¡erent from the renal organic cation transporter. However, no de¢nitive conclusions can be drawn, since our study is much more extensive, including also serine, tyrosine and lysine residues, which were not investigated by Katsura et al. [50] .
It must be emphasized that, in general, the results of experiments with chemical blockers have often been found to have a larger in£uence on activity than with mutagenesis, probably because of the steric e¡ects caused by the relatively bulky labeling reagents [63, 64] . Thus the results reported here will be fully appreciated only after the amino acid sequences of the T intestinal and renal transporters have been found and mutagenesis experiments performed. For example, the involvement of essential arginine residues in the Na dependent renal transport of glucose was previously suggested by Strevey et al. [65] by using PGO treated BBMVs. Cloned sequences for Na dependent glucose transporters SGLT1 and SGLT2 con¢rmed important arginine groups in at least two di¡erent domains [66] .
